Business Context and Reporting Period
Company: Amerigon Incorporated (Note: Input metadata listed "Gentherm Inc," but the filing text identifies the registrant as Amerigon Incorporated).
Reporting Period: Quarterly Report (Form 10-Q) for the period ended September 30, 2007.
Business Overview: Amerigon designs and markets proprietary thermoelectric devices, primarily the ClimateControl Seat (CCS), which provides heating and cooling for automotive seats. The company sells to original equipment manufacturers (OEMs) including Ford, GM, Toyota, Nissan, and Hyundai. As of September 2007, over 3.3 million CCS units had been shipped since 2000.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 2007 | Nine Months Ended Sep 30, 2007 |
|---|---|---|
| Product Revenues | $15,909,000 | $47,240,000 |
| Gross Margin | $5,173,000 (32.5%) | $15,542,000 (32.9%) |
| Operating Income | $1,683,000 | $5,393,000 |
| Net Income | $3,056,000 | $5,606,000 |
| Diluted EPS | $0.13 | $0.25 |
| Cash & Cash Equivalents | $1,795,000 | $1,795,000 (Balance Sheet) |
| Short-term Investments | $18,650,000 | $18,650,000 (Balance Sheet) |
| Total Liabilities | $12,267,000 | $12,267,000 (Balance Sheet) |
| Working Capital | $27,830,000 | $27,830,000 (Balance Sheet) |
Cash Flow (Nine Months 2007): Net cash provided by operating activities was $9,374,000. Net cash used in investing activities was $10,457,000, primarily due to purchases of short-term investments and patent costs. Net cash provided by financing activities was $441,000.
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 25% in Q3 2007 and 33% year-to-date (YTD) compared to 2006. This was driven by new model introductions (e.g., Jaguar XJ, Lexus 600HL) and higher volumes on redesigned models, partially offset by lower average unit prices due to product mix changes.
- Profitability: Net income for Q3 2007 was $3.056 million compared to $900,000 in Q3 2006. YTD net income was $5.606 million versus $2.484 million in 2006.
- Tax Benefit: A significant non-cash income tax benefit of $1,083,000 was recorded in Q3 2007 due to the recognition of approximately $1.7 million in R&D tax credits for the period 1999–2006. This resulted in an effective tax rate of -54.9% for the quarter.
- Inventory Reduction: Inventory decreased by 68% year-over-year to $1.403 million, attributed to management efforts to reduce levels and increased direct shipping from contract manufacturers.
- R&D Expenses: Net R&D expenses increased 38% in Q3 and 53% YTD due to increased activity in advanced thermoelectric device (TED) programs and reduced reimbursements from partner Visteon Corporation.
Guidance, Outlook, and Risks
Management Commentary:
- Outlook: Management expects net R&D expenses to increase in the remainder of 2007 and in 2008 as development of advanced TED technology continues. Reimbursements from partners may not increase proportionately.
- Partnerships: BSST (subsidiary) modified its agreement with Visteon to acquire Visteon's HVAC technology ($1.5 million capitalized) and seek new partners in Asia and Europe. Until new partnerships are finalized, Amerigon will fund a larger portion of BSST operations.
- Liquidity: The company believes current cash, short-term investments, and a $10 million revolving line of credit (currently unutilized) are sufficient to meet operating needs for the foreseeable future.
Risks and Contingencies:
- Single Product Reliance: The company relies almost exclusively on the CCS product; failure to commercialize additional TED products could limit growth.
- Supplier Concentration: Production is outsourced to Ferrotec Corporation in China. Disruptions or loss of this supplier could materially affect operations.
- Customer Concentration: Sales depend on acceptance by major OEMs. Customers reserve the right to cancel contracts or reduce prices unilaterally.
- Intellectual Property: Risks include the inability to protect patents or potential litigation regarding infringement.
Investor Verification Checklist
- Tax Credit Sustainability: Verify the permanence of the $1.7 million R&D tax credit benefit and its impact on future effective tax rates.
- BSST Funding Requirements: Monitor the timeline for securing new development partners for BSST to assess future cash burn rates for R&D.
- Supplier Concentration: Review the terms and stability of the manufacturing agreement with Ferrotec Corporation in China.
- Product Mix Impact: Analyze the trend of average selling prices (ASP) as the product mix shifts toward systems with lower Amerigon content.
- Inventory Management: Confirm that the 68% inventory reduction is sustainable and does not risk supply chain disruptions.